Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
19 déc. 2024 07h00 HE
|
Lexeo Therapeutics
Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer